Press Release: Moberg Pharma : Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients

/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in the ongoing...